Polyphenol-loaded polycaprolactone nanofibers for effective growth inhibition of human cancer cells

被引:65
作者
Kim, Young-Jin [2 ]
Park, Mi Ran [1 ]
Kim, Min Sung [2 ]
Kwon, Oh Hyeong [1 ]
机构
[1] Kumoh Natl Inst Technol, Dept Polymer Sci & Engn, Gumi 730701, South Korea
[2] Catholic Univ Daegu, Dept Biomed Engn, Gyongsan 712702, South Korea
基金
新加坡国家研究基金会;
关键词
Biomaterials; Polymers; Nanostructures; Diffusion; DRUG-DELIVERY; IN-VITRO; CONTROLLED-RELEASE; TEA POLYPHENOLS; CAFFEIC ACID; FLAVONOIDS; BEHAVIOR; ANTIOXIDANTS; COLLAGEN; CULTURE;
D O I
10.1016/j.matchemphys.2012.01.050
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The use of polymeric nanofibers as drug carriers can be promising in the future for biomedical applications, especially postoperative local chemotherapy. PCL is a biodegradable polyester that has been frequently explored as implantable carriers for drug delivery systems. To develop a drug carrier that enables cancer therapy, plant polyphenol-loaded PCL nanofibers were fabricated by electrospinning. The resulting nanofibers exhibited a fully interconnected pore structure and their average diameter was increased by the addition of plant polyphenol. ATR-FTIR and XRD results clearly revealed the existence of intermolecular interaction between PCL and plant polyphenol in nanofibers. The crystallinity obtained from the DSC data increased with the incorporation of plant polyphenol from 52.0% to 57.8%. The nanofibers showed no burst release and controlled release of EGCG and CA, which implied the homogenous dispersion and perfect inclusion of plant polyphenol within the nanofibers. The released plant polyphenol can generate H2O2, which is the major cause of cytotoxicity of EGCG and CA. Moreover, H2O2 generated by plant polyphenol is mainly involved in apoptosis of gastric cancer cells by activation of caspase-3. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:674 / 680
页数:7
相关论文
共 47 条
[1]   Cytotoxic effects of digalloyl dimer procyanidins in human cancer cell lines [J].
Actis-Goretta, Lucas ;
Romanczyk, Leo J. ;
Rodriguez, Carla A. ;
Kwik-Uribe, Cathenne ;
Keen, Carl L. .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2008, 19 (12) :797-808
[2]   Preparation and characterization of starch-poly-ε-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications [J].
Balmayor, E. R. ;
Tuzlakoglu, K. ;
Azevedo, H. S. ;
Reis, R. L. .
ACTA BIOMATERIALIA, 2009, 5 (04) :1035-1045
[3]   Precise control of PLG microsphere size provides enhanced control of drug release rate [J].
Berkland, C ;
King, M ;
Cox, A ;
Kim, K ;
Pack, DW .
JOURNAL OF CONTROLLED RELEASE, 2002, 82 (01) :137-147
[4]   Prooxidant DNA breakage induced by caffeic acid in human peripheral lymphocytes: Involvement of endogenous copper and a putative mechanism for anticancer properties [J].
Bhat, S. H. ;
Azmi, A. S. ;
Hadi, S. M. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 218 (03) :249-255
[5]   Dietary agents in cancer prevention: flavonoids and isoflavonoids [J].
Birt, DF ;
Hendrich, S ;
Wang, WQ .
PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) :157-177
[6]   Physicochemical characterisation of degrading polycaprolactone scaffolds [J].
Bosworth, Lucy A. ;
Downes, Sandra .
POLYMER DEGRADATION AND STABILITY, 2010, 95 (12) :2269-2276
[7]   Hydrogel-based drug delivery systems: Comparison of drug diffusivity and release kinetics [J].
Brandl, Ferdinand ;
Kastner, Fritz ;
Gschwind, Ruth M. ;
Blunk, Torsten ;
Tessmar, Joerg ;
Goepferich, Achim .
JOURNAL OF CONTROLLED RELEASE, 2010, 142 (02) :221-228
[8]  
Caccetta RAA, 2000, AM J CLIN NUTR, V71, P67
[9]   Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells [J].
Chen, C ;
Shen, GX ;
Hebbar, V ;
Hu, R ;
Owuor, ED ;
Kong, ANT .
CARCINOGENESIS, 2003, 24 (08) :1369-1378
[10]   The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(L-lactide-co-ε-caprolactone) as stent-coating materials [J].
Cho, Han Hee ;
Han, Dong-Wook ;
Matsumura, Kazuaki ;
Tsutsumi, Sadami ;
Hyon, Suong-Hyu .
BIOMATERIALS, 2008, 29 (07) :884-893